Related Experiment Video
Updated: Mar 11, 2026
09:12
Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
Published on: October 17, 2018
59.4K
MicroRNA profiling of human intermediate monocytes.
Adam M Zawada1, Lu Zhang2, Insa E Emrich1
1Department of Internal Medicine IV, Saarland University Medical Center, Homburg, Germany.
Immunobiology
|November 24, 2016
Summary
Intermediate monocytes, key to inflammation and cardiovascular risk, possess a unique microRNA (miRNA) profile. This study reveals specific miRNAs in these cells, offering targeted therapeutic potential.
Area of Science:
- Immunology
- Epigenetics
- Molecular Biology
Background:
- Human monocytes comprise three subsets: classical, intermediate, and non-classical.
- Intermediate monocytes (CD14++CD16+) are linked to inflammation and cardiovascular disease risk.
- MicroRNAs (miRNAs) are crucial epigenetic regulators of gene expression.
Purpose of the Study:
- To investigate the distinct miRNA expression profile of intermediate monocytes.
- To identify specific miRNAs that characterize intermediate monocytes compared to other subsets.
- To explore the functional implications of these differentially expressed miRNAs.
Main Methods:
- Small RNA sequencing (small RNA-seq) was employed to analyze miRNA expression.
- 662 miRNAs were quantified across classical, intermediate, and non-classical monocyte subsets.
- Statistical analysis identified differentially expressed miRNAs with high significance (p <10^-10).
Main Results:
- 38 miRNAs were significantly differentially expressed in intermediate monocytes.
- miR-6087 (upregulated) and miR-150-5p (downregulated) showed >10-fold expression changes.
- Pathway analysis linked these miRNAs to gene regulation, cell differentiation, and immune signaling.
Conclusions:
- This study provides the first genome-wide miRNA data for human monocyte subsets.
- Distinct miRNA profiles support the concept of monocyte trichotomy in human immunity.
- Identifying intermediate monocyte-specific miRNAs may enable targeted therapeutic strategies.
